© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Jeffrey Weber Explains Organ-Specific Side Effects of Checkpoint Inhibitors
November 1, 2016
Jeffrey Weber, MD, PhD
Jeffrey Weber, MD, PhD
Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.
Jeffrey Weber, MD, PhD, from NYU Langone Perlmutter Cancer Center explains the different organ-specific side effects that can occur when a patient is on checkpoint inhibitors. These toxicities can progress quickly and to fatal levels; therefore, patients need careful attention.
For example, an increase in pancreas function can present without any symptoms and requires monitoring of the patient’s lab results. Inflammation in the lungs can become pneumonitis, which can become fatal if not caught in time.
Related Content: